Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ericka L. Smith"'
Autor:
Alex C. Rutkovsky, Jamie N. Mills, Brittany Turner-Ivey, Stephen P. Ethier, Ericka L. Smith, Laura Spruill
NSD3 has been implicated as a candidate driver oncogene from the 8p11-p12 locus, and we have previously published evidence for its amplification and overexpression in human breast cancer. This aim of this study was to further characterize the transfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ffa068f355588b96b898032f109f8c3
https://europepmc.org/articles/PMC5928774/
https://europepmc.org/articles/PMC5928774/
Autor:
Jamie N. Mills, Stephen P. Ethier, Laura Spruill, Ericka L. Smith, Alex C. Rutkovsky, Brittany Turner-Ivey
Publikováno v:
Cancer Research. 77:1835-1835
Amplification within the 8p11-12 locus occurs in approximately 15% of breast cancer (BC) and is associated with poor survival and distant recurrence. Overexpression of many of the genes within the 8p11-12 region can confer a pathological gain of func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20606d05c136f3acc3cb080f41bff6c8
https://doi.org/10.1158/1538-7445.am2017-1835
https://doi.org/10.1158/1538-7445.am2017-1835
Publikováno v:
Cancer Research. 76:4596-4596
Although the basal-like 1 (BL1) and BL2 subtypes of triple negative breast cancer (TNBC) share similar genetic and biological characteristics, patients with BL2 type tumors have markedly poorer prognosis. In addition, despite the overexpression of ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6377e6e1520f4e53b7a213abea061c3
https://doi.org/10.1158/1538-7445.am2016-4596
https://doi.org/10.1158/1538-7445.am2016-4596
Autor:
Stephen Guest, Stephen P. Ethier, Zachary Kratche, Christiana S. Kappler, Jonathan C. Irish, Elizabeth Garrett-Mayer, Ericka L. Smith
Publikováno v:
Cancer Research. 75:1949-1949
A subset of triple negative breast cancer (TNBC) is characterized by overexpression of the epidermal growth factor receptor (EGFR) and loss of PTEN, and patients with these factors have a poor prognosis. In addition, approximately half of all basal b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5effbf95683a8bb6759d19f8c8569655
https://doi.org/10.1158/1538-7445.am2015-1949
https://doi.org/10.1158/1538-7445.am2015-1949